What Trump's Generic Drug Tariffs Could Cost Americans Now
Policy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesPolicy experts say what trump's generic drug tariffs could mean for prices and supplies is uncertain, with effects de...
Goldman Sachs moves to remove DEI requirements for its board as conservative pressure grows. The move signals a wider...
After-hours trading is lighting up for NVIDIA as investors react to AI-driven demand and strong results. Read how to ...
here thursday’s wall street mood shifts as fresh analyst notes touch on Astera Labs, Block, Digital Realty and others...
A Florida federal court dismissed CT Realtors, Smart MLS, and WeSERV from Zea’s lawsuit, signaling a narrower path fo...
Markets move to risk-off mode as geopolitical threats push U.S. stock futures sink. Traders weigh energy prices, infl...
A bold HOA reform in Georgia aims to curb excesses, protect buyers, and sharpen lender risk assessments. This could c...
TriSalus investors are eyeing the Q1 2026 earnings update to gauge cash runway, pipeline progress, and milestone-driv...
The United States appears to be nearing a practical ceiling in its sanctions campaign against Iran, raising questions...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
Global markets edge higher as AI spending sustains profits and optimism into the summer. Analysts say tech leadership...
XRPL posted the strongest 90-day RWAs inflow among major blockchains, narrowly topping Ethereum and Solana. Analysts ...